US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers

By Reuters News

US stock indexes were mixed on Monday, with tech heavyweights facing heat as oil prices touched their highest in about two weeks ahead of big bank earnings and inflation data due later in the week that could potentially steer the Fed's policy path. .N

At 11:30 EDT, the Dow Jones Industrial Average .DJI was up 0.47% at 51,897.10. The S&P 500 .SPX was down 0.06% at 7,807.43, and the Nasdaq Composite .IXIC was down 0.30% at 27,287.53.


The top three S&P 500 .PG.INX percentage gainers:

** eBay EBAY.O, up 5.25%
** Fair Isaac FICO.N, up 5.50%
** Meta META.O, up 3.81%


The top three S&P 500 .PL.INX percentage losers:

** Ciena Corp CIEN.N, down 8.94%
** Lumentum LITE.O, down 8.96%
** Bloom Energy BE.N, down 6.51%


The top three NYSE .PG.N percentage gainers:

** Mesa Royalty MTR.N, up 4.78%
** Londian Wason FOIL.N, up 5.99%
** FIGS FIGS.N, up 9.70%


The top three NYSE .PL.N percentage losers:

** Yiren Digital YRD.N, down 44.05%
** Mogu MOGU.N, down 17.11%
** Four Seasons Education FEDU.N, down 11.51%


The top three Nasdaq .PG.O percentage gainers:

** Meta META.O, up 3.81%
** Shopify SHOP.TO, , up 3.13%
** GE Healthcare GEHC.O, up 2.97%


The top three Nasdaq .PL.O percentage losers:

** Lumentum LITE.O, down 8.96%
** SanDisk SNDK.O, down 5.66%
** Nebius NBIS.O, down 4.76%


** Contineum CTNM.O:

BUZZ - Contineum tumbles as Bristol's partial trial win raises dose doubts


** C3.ai AI.N:

BUZZ - C3.ai gains after Northland Capital upgrade


** Starbucks SBUX.O, Chipotle CMG.N:

BUZZ - Starbucks up, Chipotle falls after coffee chain says not buying burrito chain


** T-Mobile TMUS.O:

BUZZ - T-Mobile gains as Raymond James upgrades to 'outperform'


** Artisan Partners APAM.N:

BUZZ - Artisan Partners slips after September AUM misses expectations


** eBay EBAY.O:

BUZZ - eBay rises as Morgan Stanley names it top pick


** Steris STE.N:

BUZZ - Steris gains on $2.1 bln Xodus Medical buy


** Microsoft MSFT.O:

BUZZ - Microsoft becomes $4 trillion company once again a year later


** Fastenal FAST.O:

BUZZ - Fastenal gains after Jefferies raises PT


** Bristol Myers BMY.N:

BUZZ - Bristol Myers rises on positive trial results for cancer and lung disease drugs


** Dauch Corp DCH.N:

BUZZ - Dauch Corp rises after naming new finance chief


** Salesforce CRM.N:

BUZZ - BofA double-upgrades co to 'buy'; shares rise


** Brown & Brown BRO.N:

BUZZ - TD Cowen starts coverage with 'buy'


** IonQ IONQ.N:

BUZZ - Shares fall on $1.3 billion acquisition of cybersecurity co Elisity


** Harmony Biosciences HRMY.O:

BUZZ - CEO Dayno to retire, COO to take over; shares fall


** First Tracks Biotherapeutics TRAX.O:

BUZZ - Shares surge on positive results from celiac disease drug trial


** Enovix ENVX.O:

BUZZ - Shares rise on higher Q3 prelim revenue


** GoDaddy GDDY.N:

BUZZ - RBC downgrades rating on AI disruption fears


** Biogen BIIB.O:

BUZZ - J.P. Morgan upgrades to 'overweight', shares rise


** IREN IREN.O:

BUZZ - Shares climb on report of multi-year cloud deal with Anthropic

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.